Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bundamedik Tbk (BMHS) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance

Bundamedik TbkTrade
Saraswanti Indoland Development Tbk.Trade

Price performance (Past 24H)

Key statistics

Bundamedik Tbk vs Saraswanti Indoland Development Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp93 (market cap 490.04B, 960.5K 24h volume). The key difference: Bundamedik Tbk is far larger — about 3.1× Saraswanti Indoland Development Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (960.5K versus 536.7K). Which is the better fit depends on your goals.

BMHSSWID
Market Cap
1.51T490.04B
Volume
536.7K960.5K
Lot
5.37K9.61K
Turnover
93.41M87.63M
Average Price
174.0591.23
Value
93.41M87.63M
Indicative Equilibrium Price
17693
Indicative Equilibrium Volume
10012

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMHS
View details
SWID
View details

About Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Read more on BMHS

About Saraswanti Indoland Development Tbk.

PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.

Read more on SWID